{"name":"Artivion","slug":"artivion","ticker":"AORT","exchange":"NASDAQ","domain":"artivion.com","description":"Artivion, Inc. is a distributor of cryogenically preserved human tissues for cardiac and vascular transplant applications and develops medical devices. Among its products are human heart valves, which are treated to remove excess cellular material and antigens, and BioGlue surgical adhesive.","hq":"Kennesaw, GA","founded":0,"employees":"1800","ceo":"J. Patrick Mackin","sector":"Cardiac & Vascular Surgery","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":22.85,"stockChange":0.62,"stockChangePercent":2.79,"marketCap":"$1.1B","metrics":{"revenue":458688992,"revenueGrowth":17.5,"grossMargin":64.6,"rdSpend":30991000,"netIncome":9768000,"cash":55764000,"dividendYield":0,"peRatio":91.4,"fiscalYear":"FY2021"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2025-06-01","label":"Gel-FOAM patent cliff ($20.0M at risk)","drug":"Gel-FOAM","type":"patent_expiry","sentiment":"negative"},{"date":"2027-06-01","label":"BioFoam patent cliff ($15.0M at risk)","drug":"BioFoam","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[{"date":"2024-02-27","type":"earnings","headline":"Artivion Reports Fourth Quarter and Full Year 2023 Financial Results","summary":"Artivion reported revenue of $123.4 million for the fourth quarter of 2023, a decrease of 3.4% compared to the same period in 2022. The company reported a net loss of $14.1 million for the quarter.","drugName":"","sentiment":"neutral"},{"date":"2023-08-01","type":"deal","headline":"Artivion Announces Agreement to Acquire Certain Assets from Medtronic","summary":"Artivion has entered into an agreement to acquire certain assets from Medtronic, including a portfolio of cardiovascular grafts and surgical instruments.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxNak1zZ2kzTXNFcDI2RVllbExDUjZwVHVtMHJRZm5XLWpGUDJPWjBVYUdGamd1eFlFZEF1R0d5c1BDVWpYMGlidW5Yc2NRLUp2Q1REU0pPdWpXeVZpUGNvSVhUV2JtbkdtYlNHV1lqYjRLbHJKTFNHdXoxRFAzLUFBZjdQNjRBOFJjdXhpdThfR3F6czhHcXc?oc=5","date":"2026-04-07","type":"pipeline","source":"Yahoo Finance UK","summary":"Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know - Yahoo Finance UK","headline":"Artivion, ANI Pharmaceuticals, and Privia Health Shares Are Soaring, What You Need To Know","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxQRm1pV2VLal9Ua0h0T053NTR3dDlEYWtUUFhjTHlSdzhJYVdnbnE2UHYyRnVOTlFIdDdkUkFBQzN2al9xV1RpR21WdlV0V3F0T0lBMWZUaWZORXczOE5hTW1JclliSGkzdVR1TWd3SGsta3k4YnZnaXdOQmNNY0hEeEJTR3dRSGQ1Q1JBcDYzTmZvX1g5UG9EZHJ0N21LN1E?oc=5","date":"2026-04-06","type":"pipeline","source":"TradingView","summary":"Why Artivion (AORT) Stock Is Down Today - TradingView","headline":"Why Artivion (AORT) Stock Is Down Today","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUEFVX3lxTE1zVFh1cVdyWHRXNjA4czBMTlVXOGFRdlozWDNfWndvT1d4Wk96VGwxU0R3b3RPNE9KVi1jSklrYUpqMHhxdVJ6MXFmQTBPNFpW?oc=5","date":"2024-03-13","type":"pipeline","source":"CNN","summary":"symbol__ Stock Quote Price and Forecast - CNN","headline":"symbol__ Stock Quote Price and Forecast","sentiment":"neutral"}],"patents":[{"drugName":"Gel-FOAM","drugSlug":"gelatin-based-foam","patentNumber":"","type":"Patent Cliff","expiryDate":"2025-06-01","territory":"US","annualRevenue":20000000},{"drugName":"BioFoam","drugSlug":"bioabsorbable-foam","patentNumber":"","type":"Patent Cliff","expiryDate":"2027-06-01","territory":"US","annualRevenue":15000000}],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":2,"keyCompetitors":["Medtronic","Becton Dickinson","Boston Scientific"],"therapeuticFocus":["Cardiovascular Surgery","Vascular Surgery"],"financials":{"source":"sec_edgar+yahoo","revenue":298836000,"revenuePeriod":"2021-12-31","revenueHistory":[{"value":298836000,"period":"2021-12-31"},{"value":253227000,"period":"2020-12-31"},{"value":253227000,"period":"2020-12-31"},{"value":276222000,"period":"2019-12-31"},{"value":276222000,"period":"2019-12-31"}],"grossProfit":284227000,"grossProfitHistory":[{"period":"2025-12-31","value":284227000},{"period":"2024-12-31","value":248781000},{"period":"2023-12-31","value":229176000},{"period":"2022-12-31","value":202523000}],"rdSpend":30991000,"rdSpendHistory":[{"period":"2025-12-31","value":30991000},{"period":"2024-12-31","value":28452000},{"period":"2023-12-31","value":28707000},{"period":"2022-12-31","value":38879000}],"sgaSpend":226491000,"operatingIncome":26745000,"operatingIncomeHistory":[{"period":"2025-12-31","value":26745000},{"period":"2024-12-31","value":38874000},{"period":"2023-12-31","value":-8508000},{"period":"2022-12-31","value":6201000}],"netIncome":9768000,"netIncomeHistory":[{"period":"2025-12-31","value":9768000},{"period":"2024-12-31","value":-13359000},{"period":"2023-12-31","value":-30690000},{"period":"2022-12-31","value":-19192000}],"eps":-0.32,"epsHistory":[{"period":"2024-12-31","value":-0.32},{"period":"2023-12-31","value":-0.75},{"period":"2022-12-31","value":-0.48},{"period":"2021-12-31","value":-0.38}],"cash":64908000,"cashHistory":[{"period":"2025-12-31","value":64908000},{"period":"2024-12-31","value":53463000},{"period":"2023-12-31","value":58940000},{"period":"2022-12-31","value":39351000}],"totalAssets":884796000,"totalLiabilities":436564000,"totalDebt":257614000,"equity":448232000,"operatingCashflow":39880000,"operatingCashflowHistory":[{"period":"2025-12-31","value":39880000},{"period":"2024-12-31","value":22236000},{"period":"2023-12-31","value":18825000},{"period":"2022-12-31","value":-5153000}],"capex":-39041000,"capexHistory":[{"period":"2025-12-31","value":-39041000},{"period":"2024-12-31","value":-11188000},{"period":"2023-12-31","value":-9752000},{"period":"2022-12-31","value":-10715000}],"freeCashflow":839000,"dividendsPaid":null,"buybacks":0,"employees":1800,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[{"sga":56841000,"ebit":12067000,"ebitda":17824000,"period":"2025-12-31","revenue":115992000,"epsBasic":0.05,"netIncome":2426000,"rdExpense":9122000,"epsDiluted":0.05,"grossProfit":73143000,"operatingIncome":7180000},{"sga":57281000,"ebit":13175000,"ebitda":18892000,"period":"2025-09-30","revenue":113388000,"epsBasic":0.14,"netIncome":6502000,"rdExpense":8078000,"epsDiluted":0.13,"grossProfit":74395000,"operatingIncome":9036000},{"sga":57665000,"ebit":10752000,"ebitda":16290000,"period":"2025-06-30","revenue":112972000,"epsBasic":0.03,"netIncome":1345000,"rdExpense":7063000,"epsDiluted":0.03,"grossProfit":73112000,"operatingIncome":8384000},{"sga":54704000,"ebit":5368000,"ebitda":10814000,"period":"2025-03-31","revenue":98978000,"epsBasic":-0.01,"netIncome":-505000,"rdExpense":6728000,"epsDiluted":-0.01,"grossProfit":63577000,"operatingIncome":2145000},{"sga":51429000,"ebit":-6860000,"ebitda":-565000,"period":"2024-12-31","revenue":97308000,"epsBasic":-0.39,"netIncome":-16483000,"rdExpense":7404000,"epsDiluted":-0.39,"grossProfit":61502000,"operatingIncome":2669000},{"sga":null,"ebit":null,"ebitda":null,"period":"2024-09-30","revenue":null,"epsBasic":null,"netIncome":null,"rdExpense":null,"epsDiluted":null,"grossProfit":null,"operatingIncome":null}]},"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":22.85,"previousClose":22.23,"fiftyTwoWeekHigh":48.25,"fiftyTwoWeekLow":19.16,"fiftyTwoWeekRange":"19.16 - 48.25","fiftyDayAverage":35.36,"twoHundredDayAverage":40.58,"beta":1.4,"enterpriseValue":1281511680,"forwardPE":28.3,"priceToBook":2.46,"priceToSales":2.42,"enterpriseToRevenue":2.79,"enterpriseToEbitda":20.87,"pegRatio":0,"ebitda":61403000,"ebitdaMargin":13.4,"freeCashflow":-7293625,"operatingCashflow":57987000,"totalDebt":258156992,"debtToEquity":57.3,"currentRatio":3.86,"returnOnAssets":2.8,"returnOnEquity":3.1,"analystRating":"1.1 - Strong Buy","recommendationKey":"strong_buy","numberOfAnalysts":8,"targetMeanPrice":42.88,"targetHighPrice":48,"targetLowPrice":36,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":1449619200,"insiderHeldPercent":4.5,"institutionHeldPercent":94.8,"sharesOutstanding":48543350,"floatShares":46025892,"sharesShort":1920829,"shortRatio":4.51,"shortPercentOfFloat":4,"epsTrailing":0.25,"epsForward":0.81,"revenuePerShare":9.8,"bookValue":9.29,"officers":[{"age":58,"name":"Mr. James Patrick Mackin","title":"Chairman, President & CEO"},{"age":53,"name":"Mr. Lance A. Berry CPA","title":"EVP, COO, CFO & Treasurer"},{"age":68,"name":"Ms. Jean F. Holloway Esq.","title":"Senior VP, General Counsel, Chief Compliance Officer & Corporate Secretary"},{"age":60,"name":"Mr. John E. Davis","title":"Senior VP & Chief Commercial Officer"},{"age":55,"name":"Ms. Amy D. Horton CPA","title":"VP & Chief Accounting Officer"},{"age":56,"name":"Mr. Matthew A. Getz","title":"VP of Human Resources & Chief Human Resources Officer"},{"age":49,"name":"Mr. Jason D. Asper","title":"Senior VP and Chief Strategy & Digital Officer"},{"age":56,"name":"Mr. Andrew M. Green","title":"Senior Vice President of Regulatory & Quality"}],"industry":"Medical Devices","irWebsite":"http://phx.corporate-ir.net/phoenix.zhtml?c=80253&p=irol-IRHome","website":"https://artivion.com","phone":"770 419 3355"}}